7.1
65
NDA / BLA / MAA Strategy
Define application strategy, filing readiness, regulatory pathway, risks, and governance.
View toolkitStage 7
Marketing application and approval
Documentation for assembling, reviewing and defending the evidence required for marketing authorisation.
What this stage covers
NDA, BLA and MAA strategy, CTD/eCTD modules, integrated summaries, benefit-risk, labelling, and pre-approval inspection readiness.
How it helps your team: Coordinate dossier evidence and response ownership before filing pressure exposes gaps.
10 toolkits
Choose the operational area you need
7.2
65
CTD / eCTD Dossier Management
Manage dossier modules, ownership, QC, publishing, and submission content.
View toolkit7.3
64
Module 2 Summary Development
Develop and review quality, nonclinical, and clinical summaries.
View toolkit7.4
64
Module 3 CMC Submission
Prepare CMC submission module content and data readiness.
View toolkit7.5
64
Module 4 Nonclinical Submission
Prepare nonclinical module content, summaries, study reports, and consistency checks.
View toolkit7.6
64
Module 5 Clinical Submission
Prepare clinical study reports, datasets, listings, and clinical data package readiness.
View toolkit7.7
65
Integrated Summary of Safety / Efficacy
Govern integrated safety and efficacy analyses, pooling strategy, datasets, and review.
View toolkit7.8
65
Benefit-Risk & Labeling
Manage benefit-risk evidence, labeling claims, SmPC/PI/PIL, and negotiation readiness.
View toolkit7.9
65
Health Authority Question Response Management
Manage authority questions, response strategy, ownership, deadlines, and commitments.
View toolkit7.10
65
Pre-Approval Inspection Readiness
Prepare manufacturing, clinical, sponsor, and quality systems for pre-approval inspection.
View toolkitNot sure which toolkit fits the work?
Return to the full catalogue and search by process, study, submission or control.